Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease (Q41622546)

5 October 2017

1 reference

title

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease (English)

1 reference

5 October 2017

1 reference

Richardson PJ

1

1 reference

PubMed ID

9345853

5 October 2017

Kase H

series ordinal

2

1 reference

PubMed ID

9345853

5 October 2017

Jenner PG

series ordinal

3

1 reference

5 October 2017

1 September 1997

1 reference

Trends in Pharmacological Sciences

5 October 2017

1 reference

5 October 2017

18

1 reference

5 October 2017

9

1 reference

5 October 2017

338-344

1 reference

The pharmacology of Parkinson's disease therapy: an update

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Drug treatment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Neurotransmitters and neuromodulators in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Striatal interneurones: chemical, physiological and morphological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Dopamine receptor subtypes colocalize in rat striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Tissue distribution of adenosine receptor mRNAs in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

(E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Pharmacology of adenosine A2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Muscarinic modulation of a transient K+ conductance in rat neostriatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Both A1 and A2a purine receptors regulate striatal acetylcholine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

The effect of theophylline on parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901096-1

7 January 2021

10.1016/S0165-6147(97)01096-1

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9345853